Published financial brief
3799B
HEALTHMARKETS INC
- As of
- 2012-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 3 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
3 reported periods
| Metric | FY 20102010-12-31 | FY 20112011-12-31 | FY 20122012-12-31 |
|---|---|---|---|
| Financial statements | |||
| RevenueUSD millions | 861.7 | 665.2 | 568.3 |
| Cost of goods soldUSD millions | 728.5 | 611 | 549.4 |
| Selling, general and administrative expenseUSD millions | —missing | —missing | —missing |
| Depreciation and amortizationUSD millions | 17.5 | 13.4 | 12.9 |
| Net incomeUSD millions | 50.1 | 10.7 | -7.3 |
| Operating profit (EBIT)USD millions | 115.7 | 40.8 | 6 |
| Income taxesUSD millions | 31.9 | 8 | 0.6 |
| Short-term debtUSD millions | 8.3 | 369.8 | 6.4 |
| Long-term debtUSD millions | 613.8 | 243.7 | 237 |
| Cash and equivalentsUSD millions | 408.5 | 675.6 | 263.4 |
| ReceivablesUSD millions | 466.6 | 439.3 | 445.1 |
| InventoryUSD millions | 0 | 0 | 0 |
| PayablesUSD millions | 256.3 | 134.7 | 117 |
| Net property, plant and equipmentUSD millions | 43.7 | 37.5 | 33.5 |
| Capital expenditureUSD millions | 9.5 | 7.2 | 5.2 |
| Operating cash flowUSD millions | -33.5 | 22.3 | -41 |
| Prepaid expensesUSD millions | 0 | 0 | 0 |
| AccrualsUSD millions | —missing | —missing | —missing |
| EBITDAUSD millions | 133.2 | 54.2 | 18.9 |
| Working capitalUSD millions | —missing | —missing | —missing |
| Working capital requirementUSD millions | 210.3 | 304.6 | 328.1 |
| Total debtUSD millions | 622.1 | 613.5 | 243.4 |
| Free cash flowUSD millions | -43 | 15.2 | -46.2 |
| Unlevered free cash flowUSD millions | 78.6 | -64.8 | -9.8 |
| Returns and ratios | |||
| ROICratio | 18.8% | 5% | 1.2% |
| Pre-tax ROICratio | 30.7% | 8.8% | 1.2% |
| Effective tax rateratio | 38.9% | 43% | 0% |
| Revenue growthratio | —missing | -22.8% | -14.6% |
| EBIT / Revenueratio | 13.4% | 6.1% | 1.1% |
| Revenue / Invested capitalmultiple | 2.29× | 1.44× | 1.17× |
| Cogs Over Revenuesratio | 84.5% | 91.9% | 96.7% |
| Sga Over Revenuesratio | —missing | —missing | —missing |
| Da Over Revenuesratio | 2% | 2% | 2.3% |
| Nfa Over Revenuesratio | 5.1% | 5.6% | 5.9% |
| Wcr Over Revenuesratio | 24.4% | 45.8% | 57.7% |
| Debt Over Ebitdamultiple | 4.67× | 11.32× | 12.9× |
| St Debt Over Cashmultiple | 0.02× | 0.55× | 0.02× |
| Interest Over Ebitdamultiple | 0.23× | 0.41× | 0.67× |
| Interest Over Nocf Nicfmultiple | -0.7× | 1.46× | -0.27× |
| Nsf Over Wcrmultiple | -1.9× | -1× | -0.78× |
Ask this snapshot
Research assistant
3799B · annualSnapshot 20d22cb1
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000